safety & efficacy of tpo-ras in elderly patients with itp
Published 1 year ago • 81 plays • Length 0:30Download video MP4
Download video MP3
Similar videos
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
5:45
advance iv results: efficacy and safety of intravenous efgartigimod in adults with primary itp
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
2:50
beacon trial results: safety & efficacy of bitopertin in adults with epp
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
0:59
the safety and efficacy of etavopivat in scd
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
44:07
trombositopenia: itp ttp hus dic - ukmppd
-
3:51
sickle cell disease | moa animation
-
9:16
protrombin time (pt) & activated partial tromboplastin time (aptt)|coagulation analyzer|wila djami
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:33
rnai therapeutics for attr amyloidosis
-
2:03
unmet needs in immune thrombocytopenia
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
27:49
tpo agents beyond itp
-
4:20
itp update: diagnosis, treatment & covid-19 vaccines
-
1:52
maic of momelotinib versus fedratinib safety in myelofibrosis
-
1:59
novel investigational drugs and promising therapies for immune thrombocytopenia